has been cited by the following article(s):
[1]
|
Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae)
Parasites & Vectors,
2023
DOI:10.1186/s13071-022-05611-1
|
|
|
[2]
|
Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae)
Parasites & Vectors,
2023
DOI:10.1186/s13071-022-05611-1
|
|
|
[3]
|
Oral pharmacokinetic profile of fipronil and efficacy against
flea
and
tick
in dogs
Journal of Veterinary Pharmacology and Therapeutics,
2022
DOI:10.1111/jvp.13004
|
|
|
[4]
|
Efficacy of a single administration of afoxolaner (NexGard®) or fipronil plus permethrin (Frontline® Tri-Act) against Hyalomma marginatum ticks in dogs
Veterinary Parasitology: Regional Studies and Reports,
2021
DOI:10.1016/j.vprsr.2021.100606
|
|
|
[5]
|
THERAPEUTIC REVIEW – ISOXAZOLINES
Journal of Exotic Pet Medicine,
2018
DOI:10.1053/j.jepm.2018.02.038
|
|
|
[6]
|
A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA
Parasites & Vectors,
2017
DOI:10.1186/s13071-017-2469-x
|
|
|